Navigation Links
VSL#3® Probiotic Shown Effective in Dietary Management of Children With Irritable Bowel Syndrome
Date:8/16/2010

GAITHERSBURG, Md., Aug. 16 /PRNewswire-USNewswire/ -- New data show that VSL#3, a high-potency probiotic medical food, provides effective dietary management of children affected with irritable bowel syndrome (IBS).  

Until recently, little has been done to understand the role of probiotics in the dietary management of children with IBS.  Now, data is available showing VSL#3 as an option for children suffering from this disorder.  These data were published in the July issue of the Journal of Pediatric Gastroenterology and Nutrition.  

"There is evidence that some probiotics, such as VSL#3, have a beneficial role in the dietary management of children and teenagers suffering with IBS," said Stefano Guandalini, MD, Professor and Chief of the Section of Pediatric Gastroenterology, Hepatology and Nutrition at the University of Chicago.  "This has the potential to make a real difference for kids who suffer from pain, bloating and discomfort of IBS."

This investigation was a randomized, double-blind, placebo-controlled, crossover trial conducted in five pediatric tertiary care centers.  Patients eligible for enrollment were male and female children in the age range of 4 to 18 years, with an IBS diagnosis.  A total of 59 children completed the study.  Although placebo was beneficial in some of the parameters and in as many as half of the patients, VSL#3 was significantly superior to placebo in reaching the primary (relief of symptoms) and most secondary endpoints (abdominal pain/discomfort, abdominal bloating/gassiness and family assessment of life disruption).

About Irritable Bowel Syndrome (IBS)

IBS is a common problem in pediatrics, for which no cure is available.  This disorder is characterized most commonly by cramping, abdominal pain, bloating, constipation, and diarrhea.  IBS causes a great deal of discomfort and distress, but it does not permanently harm the intestines and does not lead to a serious disease, such as cancer.  IBS is common in people of all ages, including children.  About 14 percent of high school students and 6 percent of middle school students report IBS-like symptoms.

About VSL#3®

VSL#3® is a high-potency probiotic medical food, containing several different strains of beneficial bacteria that were specially selected to produce an optimal composition of beneficial bacteria. VSL#3 colonizes the gastrointestinal (GI) tract with optimal quantities and types of probiotic ("good") bacteria. Using this high concentration of several different strains of specially selected beneficial bacteria, VSL#3 provides an optimal composition of good bacteria, enhancing the health of the GI tract and aiding in dietary management of IBS. Each packet of VSL#3 contains 450 billion CFU.

VSL#3® is a registered trademark of VSL Pharmaceuticals Inc.  VSL#3® is a product that has been licensed from VSL Pharmaceuticals Inc. to Sigma-Tau Pharmaceuticals, Inc. for the U.S. territory.  For more information, visit www.vsl3.com.

About Sigma-Tau Pharmaceuticals, Inc.

Sigma-Tau Pharmaceuticals, Inc. is a U.S.-based, wholly owned subsidiary of the sigma-tau Group, and is dedicated solely to the global development and commercialization of medicines for patients with rare diseases.  Sigma-Tau Pharmaceuticals, Inc. is based in Gaithersburg, Maryland.  Since 1989, the company's products have been focused on rare diseases, kidney disease, and cancer.  For more information about the company, visit www.sigmatau.com.

About VSL Pharmaceuticals Inc.

VSL Pharmaceuticals Inc. is a privately owned biotechnology company focusing on the research and development of innovative solutions derived from the concept of probiotics through numerous experimental and clinical researches. VSL#3®, its first marketed product, has been extensively studied in almost 100 original publications and is currently commercialized in 15 countries worldwide for the dietary management of conditions such as IBD ( Inflammatory Bowel Disease) and IBS (Irritable Bowel Syndrome) for adult and children.


'/>"/>
SOURCE Sigma-Tau Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. MarketsandMarkets: Global Probiotics Market Worth US$32.6 Billion by 2014
2. Ganeden Biotech Announces Grants for Early Investigators to Research Probiotic GanedenBC30
3. Awardees for the 2009 Young Investigator Grant for Probiotics Research Announced
4. New Study Shows Probiotic Strain Effective in Boosting Immune Response to Flu Virus
5. New Study Shows Probiotic Strain Effective in Improving Irritable Bowel Syndrome Symptoms
6. Kibow Biotech Obtains Australian, Chinese and Indian Patents Protecting the Composition and Basic Technology Behind Its Oral Probiotic Formulation for Chronic Kidney Failure
7. Are Muramyl Peptides the Magic Bullet in Probiotics?
8. Review of Probiotic Trial Research Finds Only Bifantis(R) Able to Claim Efficacy versus Placebo for IBS Symptoms
9. SOMA 250 MG Shown To Significantly Improve Functionality and Reduce Disability in Patients With Low Back Pain in Three Days
10. NovaBay Pharmaceuticals Announces Lead Anti-infective Product Candidate, NVC-422, Shown to be Effective in Treating Topical Fungal Infection
11. MEDIHONEY(TM) Dressings Shown to Help Improve Outcomes of Non-Healing Venous Leg Ulcers in Recent Case Series
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2021)... ... March 29, 2021 , ... The University of Texas Health Science Center ... San Antonio Multispecialty and Research Hospital, a destination center for research and treatment of ... In a nod to the COVID-19 pandemic, the ceremony was held virtually. , William ...
(Date:3/30/2021)... ... March 29, 2021 , ... Iora Health ... primary care, has partnered with Devoted Health , one of the fastest-growing ... across Maricopa County and provides seniors with the highest-quality care and experience possible, ...
(Date:3/30/2021)... CITY (PRWEB) , ... March 29, 2021 , ... ... has joined the Vaccine Credential Initiative (VCI), a group bringing together leading health ... record of vaccination status, based on open, interoperable standards. By joining the VCI ...
Breaking Medicine Technology:
(Date:3/30/2021)... , ... March 29, 2021 , ... ... the 21st Century , A Virtual Workshop Presented by WCG FDAnews and Cerulean ... 4:30 pm EDT, https://wcg.swoogo.com/modern-sop-and-quality-systems , Are one’s SOPs written for the ...
(Date:3/30/2021)... ... March 29, 2021 , ... According to data released ... reproductive age (13-44) in need of publicly funded contraception live in counties impacted by ... Colorado’s 64 counties have lost some of their Title X resources. , The ...
(Date:3/30/2021)... ... March 29, 2021 , ... Health Literacy Innovations (HLI), a ... confusion due to low health literacy today announces a new partnership with the ... work with ACAP’s member Safety Net Health Plans, those that provide comprehensive health ...
(Date:3/30/2021)... ... ... Dr. Colin Campbell is proud to announce the 1 year anniversary in their new state ... internal medicine and is a primary care specialist who has been practicing for 23 years. ... keep South Jersey healthy one patient at a time. , “Over the past year, Dr. ...
(Date:3/30/2021)... ... March 30, 2021 , ... The COVID-19 ... and survivors; their families; and their caregivers. Crossroads4Hope is addressing the needs of ... emotional support system, MyGo2Support, which meets needs of people impacted by cancer, no ...
Breaking Medicine News(10 mins):